On March 1, 2024, Jiudian Hongyang Pharmaceutical, which is wholly-owned subsidiary of Jiudian Pharmaceutical, focus on production of APIs and excipients, have Ecovadis score for the first time, it is Bronze.

Our partners: Bayer, AstraZeneca, STADA and others very appreciate it.

  After the comprehensive evaluation of the professional platform, the company has obtained international recognition in four aspects, including environmental protection and social responsibility, laying a solid foundation for cooperation with global pharmaceutical enterprises.

Jiudian harmaceutical will assume more and more social responsibilities.